Example: Heart Attack

Clinical Trials on Pemphigus

Total 51 results

NCT03762265

Active, not recruiting

A Study of PRN1008 in Patients With Pemphigus

Conditions: Pemphigus
NCT04400994

Recruiting

IVIG With Rituximab vs Rituximab as First Line Treatment of Pemphigus

Conditions: Pemphigus
NCT03780166

Withdrawn

A Study of the Safety and Tolerability of INCB050465 in Pemphigus Vulgaris

Conditions: Pemphigus Vulgaris
NCT04023149

Recruiting

Efficacy of Interleukin-2 Gargle in the Treatment of Oral Mucosa Lesion in Pemphigus Vulgaris

Conditions: Pemphigus Vulgaris
NCT02613910

Terminated

Long-Term Extension Study of Ofatumumab in Subjects With Pemphigus Vulgaris

Conditions: Pemphigus
NCT04117529

Recruiting

Phenotypic and Functional Characterisation of Human B-cell Response in Pemphigus

Conditions: Pemphigus Vulgaris; Pemphigus Foliaceus
NCT01930175

Terminated

Study of Efficacy and Safety of VAY736 in Patients With Pemphigus Vulgaris

Conditions: Pemphigus Vulgaris
NCT01974518

Unknown status

Comparative Study of Rituximab Versus Combination of Rituximab and Intravenous Cyclophosphamide in Severe Pemphigus

Conditions: Pemphigus
NCT01313923

Terminated

Evaluating Sirolimus to Treat Autoimmune Blistering Dermatosis Pemphigus

Conditions: Pemphigus
NCT01338103

Unknown status

Treatment of Pemphigus Patients With Rituximab 1000mgX2 and Assessment of Immune Status Via Cylex

Conditions: Pemphigus
NCT01299857

Completed

Long-term Clinical and Biological Evaluation of Patients With Severe Forms of Pemphigus Treated by Rituximab

Conditions: Pemphigus
NCT03177213

Unknown status

Serum IL-21 Levels in Patients With Pemphigus Vulgaris

Conditions: Pemphigus Vulgaris
NCT02704429

Completed

A Study of PRN1008 in Adult Patients With Pemphigus Vulgaris

Conditions: Pemphigus Vulgaris
NCT04598477

Not yet recruiting

A Study to Assess the Long-term Safety and Efficacy of a Subcutaneous Formulation of Efgartigimod PH20 SC in Adults With Pemphigus (Vulgaris or Foliaceus)

Conditions: Pemphigus Vulgaris; Pemphigus Foliaceus
NCT04598451

Recruiting

A Study to Assess the Efficacy and Safety of a Subcutaneous Formulation of Efgartigimod PH20 SC in Adults With Pemphigus (Vulgaris or Foliaceus)

Conditions: Pemphigus Vulgaris; Pemphigus Foliaceus
NCT00626678

Completed

Azathioprine Versus Placebo in Pemphigus Vulgaris Treated With Prednisolone

Conditions: Pemphigus Vulgaris
NCT01920477

Terminated

Efficacy and Safety of Ofatumumab in Treatment of Pemphigus Vulgaris

Conditions: Pemphigus Vulgaris
NCT02383589

Completed

A Study to Evaluate the Efficacy and Safety of Rituximab Versus Mycophenolate Mofetil (MMF) in Participants With Pemphigus Vulgaris (PV)

Conditions: Pemphigus Vulgaris
NCT03239470

Active, not recruiting

Polyclonal Regulatory T Cells (PolyTregs) for Pemphigus

Conditions: Pemphigus Foliaceus; Pemphigus Vulgaris
NCT03334058

Completed

A Study to Evaluate the Safety, PD, PK and Efficacy of ARGX-113 in Patients With Pemphigus

Conditions: Pemphigus Vulgaris; Pemphigus Foliaceus
NCT02828163

Completed

Comparison Between Injections of Steroids and Autologous Platelet Rich Plasma in the Oral Erosions of Pemphigus Vulgaris

Conditions: Oral Pemphigus Vulgaris
NCT00483119

Terminated

Randomized Trial of IVIg With or Without Cyclophosphamide in Pemphigus

Conditions: Pemphigus Vulgaris
NCT00127764

Completed

European Trial of Adjuvant Oral Glucocorticoid Pulse Therapy in Pemphigus

Conditions: Pemphigus
NCT00213512

Completed

Effect of Anti CD20 in Pemphigus Desease

Conditions: Pemphigus
NCT00283712

Completed

Use of Infliximab for the Treatment of Pemphigus Vulgaris

Conditions: Pemphigus